Clinical Trials Search at Vanderbilt-Ingram Cancer Center

TRISCEND II

Disease Sites: Not Available

Phase: N/A

Investigator: Barker, Colin

NCTID: NCT04221490

Protocol No: VALV0006

The CONFORMAL Early Feasibility Study An Evaluation of the Safety and Performance of the Conformal Left Atrial Appendage Closure for Left Atrial Appendage Occlusion

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT03616028

Protocol No: CRE-ARR0008

Bone Marrow Bank

Disease Sites: Not Available

Phase: N/A

Investigator: Thompson Arildsen, Mary Ann

NCTID:

Protocol No: VICCPED1522

Laryngeal Cancer Treatment Decision-Making: A Conjoint Analysis of Post-Treatment Priorities

Disease Sites: Not Available

Phase: N/A

Investigator: Topf, Michael

NCTID:

Protocol No: VICCHN2201

APOLLO-B - A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy)

Disease Sites: Not Available

Phase: II/III

Investigator: Hung, Rebecca

NCTID:

Protocol No: CRE-CHF0004

TYRX Health Pocket

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID:

Protocol No: CRE-ARR0012

Aveir DR i2i Study - Aveir Dual-Chamber Leadless i2i IDE Study

Disease Sites: Not Available

Phase: II

Investigator: Richardson, Travis

NCTID:

Protocol No: CRE-ARR0013

CONFORM Pivotal - An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion

Disease Sites: Not Available

Phase: II

Investigator: Ellis, Christopher

NCTID:

Protocol No: CRE-ARR0011

Sphere- Treatment of Persistent Atrial Fibrillation with the Sphere -9- mapping and ablation cathether and the AFFERA Mapping and Ablation system

Disease Sites: Not Available

Phase: II

Investigator: Richardson, Travis

NCTID:

Protocol No: CRE-ARR0015

CTQJ230A - A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients with established cardiovascular disease (CVD)

Disease Sites: Not Available

Phase: III

Investigator: Linton, MacRae

NCTID:

Protocol No: CRE-GEN0001

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form